XML 72 R61.htm IDEA: XBRL DOCUMENT v3.20.4
Note 12 - Significant Transactions (Details Textual) - USD ($)
 3 Months Ended 5 Months Ended 9 Months Ended
Oct. 31, 2019
Dec. 31, 2020
Sep. 30, 2020
Dec. 31, 2019
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Payments to Acquire Businesses, Gross           $ (0) $ 184,102,000
Amortization of Intangible Assets, Total   $ 3,828   $ 2,565   10,694 5,895
Amortization of Inventory Step-up Cost           (436,000) 5,134,000
Goodwill, Ending Balance   165,784,000     $ 141,536,000 165,784,000  
Share-based Payment Arrangement, Expense   $ 3,611,000   $ 3,260,000   $ 6,887,000 $ 5,310,000
Effective Income Tax Rate Reconciliation, Percent, Total   20.70%   11.30%   75.00% 19.20%
GPT Acquisition [Member]              
Business Acquisition, Percentage of Voting Interests Acquired 100.00%            
Payments to Acquire Businesses, Gross $ 181,547,000            
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles           $ (6,002,000)  
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory           (3,752,000)  
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Property, Plant, and Equipment           878,000  
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Accrued Expenses           1,899,000  
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Receivable           500,000  
Amortization of Intangible Assets, Total           (344,000) $ 4,801,000
Depreciation, Total             $ 66,000
Inventory Step-up Cost 8,066,000            
Amortization of Inventory Step-up Cost         $ 8,502,000 (436,000)  
Goodwill, Ending Balance $ 85,130,000 [1] $ 85,130,000       85,130,000  
Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual           23,863,000  
Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual           (7,370,000)  
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Amortization of Intangible Assets           (6,000,000)  
Business Combination, Pro Forma Information, Realized and Unrealized Gain (Loss) of Acquiree since Acquisition Date, Actual           $ 4,000  
Effective Income Tax Rate Reconciliation, Percent, Total             25.00%
GPT Acquisition [Member] | Performance Stock Units [Member] | Key GPT Employees [Member]              
Share-based Payment Arrangement, Expense             $ 358,000
GPT Acquisition [Member] | Customer Relationships [Member]              
Finite-Lived Intangible Asset, Useful Life (Year)           10 years  
GPT Acquisition [Member] | Technology-Based Intangible Assets [Member]              
Finite-Lived Intangible Asset, Useful Life (Year)           10 years  
GPT Acquisition [Member] | Cost of Sales [Member]              
Amortization of Intangible Assets, Total           $ 178,000  
GPT Acquisition [Member] | Cost of Sales [Member] | Biopharmaceutical Development [Member]              
Amortization of Intangible Assets, Total           1,101,000  
GPT Acquisition [Member] | General and Administrative Expense [Member]              
Amortization of Intangible Assets, Total           (522,000)  
Depreciation, Total     $ 207,000        
GPT Acquisition [Member] | General and Administrative Expense [Member] | Biopharmaceutical Development [Member]              
Amortization of Intangible Assets, Total           $ 5,328,000  
[1] Acquired goodwill of $85,130, all of which is allocated to the Biopharmaceutical Development reportable segment, represents the value expected to arise from organic revenues growth projections that are expected to exceed that of our legacy divisions, and the opportunity to expand into a new market with well-established market share. The goodwill acquired is not deductible for income tax purposes.